Maintenance of low disease activity and remission with etanercept–disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial

BACKGROUND: Current guidelines on the treatment of rheumatoid arthritis (RA) recommend early therapy targeting the achievement of low disease activity (LDA) or clinical remission. Little published information is available on the success of this treatment strategy in Latin America. In a subset analys...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Medicine (Baltimore)
Autores principales: Zerbini, Cristiano A.F., Abud-Mendoza, Carlos, Mendez-Patarroyo, Paul, De Angelo Andrade, Mauricio, Pedersen, Ron, Vlahos, Bonnie, Borlenghi, Cecilia Elena
Formato: Artigo
Lenguaje:Inglês
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6133462/
https://ncbi.nlm.nih.gov/pubmed/30200078
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011989
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares